Correction: HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
BMJ Publishing Group
2020-05-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/8/1/e000157corr1.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma
by: Xu Chen, et al.
Published: (2020-05-01) -
The elevated DERL3 expression indicates poor prognosis in renal clear-cell carcinoma
by: Weining Fan, et al.
Published: (2025-01-01) -
The increased ANXA5 expression indicates poor prognosis in renal clear cell carcinoma
by: Lingxiang Ran, et al.
Published: (2025-02-01) -
Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis
by: Yuanshan Cui, et al.
Published: (2021-01-01) -
Downregulation of FXYD2 Is Associated with Poor Prognosis and Increased Regulatory T Cell Infiltration in Clear Cell Renal Cell Carcinoma
by: Zedan Zhang, et al.
Published: (2022-01-01)